MOLN.SW
Molecular Partners AG
$3.39
0.11 (3.37%) Today
0.03 (0.89%) Pre-market
— up— down
Open
$3.37
$3.37Previous Close
$3.26
$3.26Day Range
$3.35 – $3.39
$3.35 – $3.3952-Week Range
$2.66 – $3.96
$2.66 – $3.96Volume
11.02K
11.02KExchange
Swiss
SwissAbout MOLN.SW
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.
Related
News
N/AN/AN/AN/AN/A
Mount Etna erupts in fiery display, disrupting hundreds of flights - Reuters
Reuters · 23m ago
UAE's ADNOC says one of its vessels came under attack while transiting Hormuz - Reuters
Reuters · 4h ago
Hormuz traffic slows further after US threatens more economic pressure on Iran - Reuters
Reuters · 4h ago
Trump says USS Abraham Lincoln deployment 'not nearly long enough' - Reuters
Reuters · 5h ago
Iran defiant on strait as Trump tells Americans to accept high gas prices - Reuters
Reuters · 6h ago